TY - JOUR
T1 - Sympathetic Blocks as a Predictor for Response to Ketamine Infusion in Patients with Complex Regional Pain Syndrome
T2 - A Multicenter Study
AU - Cohen, Steven P.
AU - Khunsriraksakul, Chachrit
AU - Yoo, Yongjae
AU - Parker, Evan
AU - Samen-Akinsiku, Christelle D.K.
AU - Patel, Nirav
AU - Cohen, Seffrah J.
AU - Yuan, Xiaoning
AU - Cheng, Jianguo
AU - Moon, Jee Youn
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Background. Ketamine infusions are frequently employed for refractory complex regional pain syndrome (CRPS), but there are limited data on factors associated with treatment response. Sympathetic blocks are also commonly employed in CRPS for diagnostic and therapeutic purposes and generally precede ketamine infusions. Objectives. We sought to determine whether demographic and clinical factors, and technical and psychophysical characteristics of sympathetic blocks are associated with response to ketamine infusion. Methods. In this multi-center retrospective study, 71 patients who underwent sympathetic blocks followed by ketamine infusions at 4 hospitals were evaluated. Sympathetically maintained pain (SMP) was defined as ≥ 50% immediate pain relief after sympathetic block and a positive response to ketamine was defined as ≥ 30% pain relief lasting over 3 weeks. Results. Factors associated with a positive response to ketamine in univariable analysis were the presence of SMP (61.0% success rate vs 26.7% in those with sympathetically independent pain; P = .009) and post-block temperature increase (5.66 6 4.20 in ketamine responders vs 3.68 6 3.85 in non-responders; P = .043). No psychiatric factor was associated with ketamine response. In multivariable analysis, SMP (OR 6.54 [95% CI 1.83, 23.44]) and obesity (OR 8.75 [95% 1.45, 52.73]) were associated with a positive ketamine infusion outcome. Conclusions. The response to sympathetic blocks may predict response to ketamine infusion in CRPS patients, with alleviation of the affective component of pain and predilection to a positive placebo effect being possible explanations.
AB - Background. Ketamine infusions are frequently employed for refractory complex regional pain syndrome (CRPS), but there are limited data on factors associated with treatment response. Sympathetic blocks are also commonly employed in CRPS for diagnostic and therapeutic purposes and generally precede ketamine infusions. Objectives. We sought to determine whether demographic and clinical factors, and technical and psychophysical characteristics of sympathetic blocks are associated with response to ketamine infusion. Methods. In this multi-center retrospective study, 71 patients who underwent sympathetic blocks followed by ketamine infusions at 4 hospitals were evaluated. Sympathetically maintained pain (SMP) was defined as ≥ 50% immediate pain relief after sympathetic block and a positive response to ketamine was defined as ≥ 30% pain relief lasting over 3 weeks. Results. Factors associated with a positive response to ketamine in univariable analysis were the presence of SMP (61.0% success rate vs 26.7% in those with sympathetically independent pain; P = .009) and post-block temperature increase (5.66 6 4.20 in ketamine responders vs 3.68 6 3.85 in non-responders; P = .043). No psychiatric factor was associated with ketamine response. In multivariable analysis, SMP (OR 6.54 [95% CI 1.83, 23.44]) and obesity (OR 8.75 [95% 1.45, 52.73]) were associated with a positive ketamine infusion outcome. Conclusions. The response to sympathetic blocks may predict response to ketamine infusion in CRPS patients, with alleviation of the affective component of pain and predilection to a positive placebo effect being possible explanations.
KW - Complex Regional Pain Syndrome
KW - Ketamine
KW - Predictive Test
KW - Reflex Sympathetic Dystrophy
KW - Stellate Ganglion Block
KW - Sympathetic Block
UR - http://www.scopus.com/inward/record.url?scp=85149183456&partnerID=8YFLogxK
U2 - 10.1093/pm/pnac153
DO - 10.1093/pm/pnac153
M3 - Article
C2 - 36269190
AN - SCOPUS:85149183456
SN - 1526-2375
VL - 24
SP - 316
EP - 324
JO - Pain Medicine (United States)
JF - Pain Medicine (United States)
IS - 3
ER -